Zobrazeno 1 - 10
of 40
pro vyhledávání: '"W. G. Tatton"'
Publikováno v:
Pure and Applied Chemistry. 71:2039-2046
In recent years, apoptotic cell death has been implicated with different progressive neurodegenerative diseases such as Parkinson's disease, Huntington's disease, Amyotrophic Lateral Sclerosis or Alzheimer's disease. The hypothesis emerged, that a dr
Autor:
S. L. Shankar, A.C. Cuello, R. M. E. Chalmers-Redman, Moshe Szyf, Susan M. Grant, W. G. Tatton
Publikováno v:
NeuroReport. 10:41-46
Metabolic hypofunction is a common finding in a number of neurodegenerative diseases, including Alzheimer's disease (AD). The strong linkage between the amyloid precursor protein (APP) and AD led us to examine whether over-expression of this protein
Autor:
W G, Tatton, R M, Chalmers-Redman
Publikováno v:
Neurology. 47:171S-183S
(-)-Deprenyl has been used to irreversibly inhibit monoamine oxidase B (MAO-B) in Parkinson's disease (PD) and Alzheimer's disease (AD) as a possible means of improving dopaminergic neurotransmission or of reducing neuronal necrosis caused by oxidati
Publikováno v:
Current Eye Research. 14:119-126
Retinal ganglion cells (RGCs) have been shown to die by apoptosis after damage to their axons caused by optic nerve crush and the death can be reduced by some neurotrophic factors. Since (-)-deprenyl can reduce apoptotic death in some neuronal system
Publikováno v:
Journal of Neuroscience Research. 38:64-74
The effect of (–)-deprenyl on the survival of axotomized adult murine facial motoneurons was investigated. Previously, (—)-deprenyl was shown to increase the number of rat facial motoneurons (FMns) surviving after axotomy at postnatal day 14, app
Publikováno v:
Journal of Neuroscience Research. 37:278-286
R(-)-deprenyl has been shown to rescue axotomized immature facial motoneurons with an efficacy comparable to that of the neurotrophic factors CNTF and BDNF (Salo and Tatton, J Neurosci Res 31:394-400, 1992; Ansari et al., J Neurosci 13:4042-4053, 199
Publikováno v:
Human brain mapping. 4(1)
Two premovement potentials, the bereitschaftspotential (BP) and negative slope (NS'), can be recorded prior to the execution of self-paced hand movements using back-averaging of scalp electrical recordings. The contributions of the contralateral and
Autor:
W. G. Tatton, P. T. Salo
Publikováno v:
Journal of Neuroscience Research. 31:394-400
Deprenyl, a monoamine oxidase B inhibitor, appears to slow the progression of neurological deficits in Parkinson's disease and cognitive decline in Alzheimer's disease. The mechanisms for the slowing of the diseases are unknown. Deprenyl can reduce t
Autor:
W. G. Tatton, C. E. Greenwood
Publikováno v:
Journal of Neuroscience Research. 30:666-672
Deprenyl slows the progression of disabling symptoms in Parkinson's disease (PD) by an unknown mechanism. It can block the action of MPTP on substantia nigra compacta (SNc) neurons by inhibiting monoamine oxidase B necessary to mediate the conversion
Publikováno v:
Magnetic Resonance in Medicine. 15:58-69
This study determines the accuracy and feasibility of using localized spin-lattice (T1) relaxation time measurements from magnetic resonance (MR) images to follow changes in extracellular/intracellular fluid ratios in defined subvolumes of living tis